SHUANG FU
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology JACKSON, TN NPI 1730495342
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TN Merck Sharp & Dohme Corporation All categories
General Payments — all program years on this page
$3,550.82
- Category: General Payments
- Program years: PY2018–2024
- Record count: 133
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,131.91 across 49 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,131.91 | 49 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $145.92 | 6 |
| Janssen Biotech, Inc. | $134.61 | 8 |
| Rigel Pharmaceuticals, Inc. | $130.80 | 1 |
| PFIZER INC. | $91.52 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $91.40 | 4 |
| Daiichi Sankyo Inc. | $79.12 | 3 |
| E.R. Squibb & Sons, L.L.C. | $69.35 | 4 |
| Ipsen Biopharmaceuticals, Inc | $50.00 | 1 |
| Incyte Corporation | $47.42 | 2 |
| Lilly USA, LLC | $40.35 | 2 |
| ABBVIE INC. | $37.68 | 2 |
| SpringWorks Therapeutics, Inc. | $30.56 | 1 |
| Agios Pharmaceuticals, Inc. | $28.74 | 2 |
| Genmab U.S., Inc. | $22.27 | 1 |
| Legend Biotech USA Inc. | $21.94 | 1 |
| BeiGene USA, Inc. | $21.76 | 1 |
| Tempus AI, Inc | $20.31 | 1 |
| GlaxoSmithKline, LLC. | $19.82 | 1 |
| EISAI INC. | $17.84 | 1 |
| Acerta Pharma LLC | $17.35 | 1 |
| Coherus Biosciences Inc. | $13.15 | 1 |
By program year
Records — PY2024 (49)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.